Faculty profile

Lisa Mielniczuk

Back to faculty

Associate ProfessorDepartment of MedicineUniversity of Ottawa

Lisa Mielniczuk

Associate Professor

Department of Medicine

Faculty of Medicine

University of Ottawa

Ottawa, Ontario, Canada

Supervision signals

Professors usually supervise graduate students in their department's programs.
21 publications in the last five years, latest in 2026.
Senior (last) author on 3 recent papers, a sign of leading a research group.

These signals come from public records, including CIHR, NSERC and SSHRC funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

Publications

816

Citations

h-index

Collaborators

Grants

Publications by year

Counts cover the works listed on the university profile; citation counts come from Dimensions.

Profiles and links

University Profile Search on Google Scholar

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Read how they describe their research on their University of Ottawa profile.

Latest papers

Real-world Persistence on Selexipag for Pulmonary Arterial Hypertension in Canada.
CJC open · 2026
Author Correction to “Canadian Cardiovascular Society/Canadian Heart Failure Society 2025 Guideline Update for Pharmacologic Management of Heart Failure With Nonreduced Ejection Fraction (LVEF > 40%) [Canadian Journal of Cardiology, Volume 41, Issue 10, Pages 1857-1874. DOI: 10.1016/j.cjca.2025.07.027]”
Canadian Journal of Cardiology · 2026
Author Correction to Canadian Cardiovascular Society/Canadian Heart Failure Society 2025 Guideline Update for Pharmacologic Management of Heart Failure With Nonreduced Ejection Fraction (LVEF > 40%) [Canadian Journal of Cardiology. Volume 41, Issue 10, Pages 1857-1874. DOI:10.1016/j.cjca.2025.07.027]
Canadian Journal of Cardiology · 2026

All 55 publications

Latest funding

What's love got to do with it? Evaluating the Healing Hearts Together program on relationship, mental health, and cardiovascular outcomes
CIHR · 2023 · Co-investigator
$100,000
Multiparametric Cardiac Positron Emission Tomography for Cardiac Allograft Vasculopathy Surveillance After Heart Transplantation: MARINER Trial
CIHR · 2022 · Co-investigator
$952,425
COVID-19 Vaccine-Induced Inflammatory Heart Disease Prevalence Registry and Cohort Study (COVID-VIHPR)
CIHR · 2021 · Co-investigator
$810,900

All 6 grants and awards

55 publications.

Real-world Persistence on Selexipag for Pulmonary Arterial Hypertension in Canada.

Weatherald J, Provencher S, Murray J, Badin M, Golden S, Mielniczuk L, Swiston J, Zhang C, Yip CYY, Mamputu JC, Millson B

CJC open2026

DOI: 10.1016/j.cjco.2025.10.009 PMID: 41766702

Author Correction to “Canadian Cardiovascular Society/Canadian Heart Failure Society 2025 Guideline Update for Pharmacologic Management of Heart Failure With Nonreduced Ejection Fraction (LVEF > 40%) [Canadian Journal of Cardiology, Volume 41, Issue 10, Pages 1857-1874. DOI: 10.1016/j.cjca.2025.07.027]”

Panel: P, Virani S, Zieroth S, Aleksova N, Anderson K, Clarke B, Ducharme A, Ezekowitz JA, Foroutan F, Giannetti N

Canadian Journal of Cardiology20261 citations

DOI: 10.1016/j.cjca.2026.03.026

Author Correction to Canadian Cardiovascular Society/Canadian Heart Failure Society 2025 Guideline Update for Pharmacologic Management of Heart Failure With Nonreduced Ejection Fraction (LVEF > 40%) [Canadian Journal of Cardiology. Volume 41, Issue 10, Pages 1857-1874. DOI:10.1016/j.cjca.2025.07.027]

Virani S, Zieroth S, Aleksova N, Anderson K, Clarke B, Ducharme A, Ezekowitz JA, Foroutan F, Giannetti N, Jain R

Canadian Journal of Cardiology2026

DOI: 10.1016/j.cjca.2025.12.030

Sex Differences of Pulmonary Arterial Hypertension Patients With and Without Cardiopulmonary Comorbidities.

Gupta S, Liang JC, Qian CJ, Zelt J, Chandy G, Contreras-Dominguez V, Stewart DJ, Foxall J, Dunne R, Mielniczuk L

The Canadian journal of cardiology2025Senior author

DOI: 10.1016/j.cjca.2025.02.007 PMID: 39938715

Canadian Cardiovascular Society/Canadian Heart Failure Society 2025 Guideline Update for Pharmacologic Management of Heart Failure With Nonreduced Ejection Fraction (LVEF > 40%)

Virani S, Zieroth S, Aleksova N, Anderson K, Clarke B, Ducharme A, Ezekowitz JA, Foroutan F, Giannetti N, Jain R

Canadian Journal of Cardiology202523 citations

DOI: 10.1016/j.cjca.2025.07.027

Corrigendum to Canadian Cardiovascular Society/Canadian Heart Failure Society 2025 Guideline Update for Pharmacologic Management of Heart Failure With Nonreduced Ejection Fraction (LVEF > 40%). Volume 41, Issue 10, October 2025, Pages 1857-74

Virani S, Zieroth S, Aleksova N, Anderson K, Clarke B, Ducharme A, Ezekowitz JA, Foroutan F, Giannetti N, Jain R

Canadian Journal of Cardiology20251 citations

DOI: 10.1016/j.cjca.2025.12.001

In search of the answers to the viability questions.

Omaygenc MO, Morgan H, Mielniczuk L, Perera D, Panza JA

Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology2024

DOI: 10.1016/j.nuclcard.2024.101912 PMID: 39370172

Risk Stratification in Cardiac Sarcoidosis With Cardiac Positron Emission Tomography: A Systematic Review and Meta-Analysis.

Kafil TS, Shaikh OM, Fanous Y, Benjamen J, Hashmi MM, Jawad A, Dahrouj T, Abazid RM, Swiha M, Romsa J, Beanlands RSB, Ruddy TD, Mielniczuk L, Birnie DH, Tzemos N

JACC. Cardiovascular imaging2024

DOI: 10.1016/j.jcmg.2024.05.013 PMID: 39115497

The HEARTRISK6 Scale: Predicting Short-Term Serious Outcomes in Emergency Department Acute Heart Failure Patients.

Stiell IG, Perry JJ, Eagles D, Yadav K, Clement CM, McRae AD, Yan JW, Mielniczuk L, Rowe BH, Borgundvaag B, Dreyer J, Brown EL, Nemnom MJ, Taljaard M

JACC. Advances2024

DOI: 10.1016/j.jacadv.2024.100988 PMID: 39129980

Characteristics, management, and outcomes in women and men with congestive heart failure in 40 countries at different economic levels: an analysis from the Global Congestive Heart Failure (G-CHF) registry

Walli-Attaei M, Joseph P, Johansson I, Sliwa K, Lonn E, Maggioni AP, Mielniczuk L, Ross H, Karaye K, Hage C

The Lancet Global Health202452 citationsOpen Access

DOI: 10.1016/s2214-109x(23)00557-0 PMID: W4390718632

Profile data last refreshed on September 25, 2026 from the university directory, publication records and CIHR, NSERC and SSHRC funding.

Something wrong or missing on this profile? Suggest a correction

Lisa Mielniczuk

Research

Latest papers

Latest funding

Real-world Persistence on Selexipag for Pulmonary Arterial Hypertension in Canada.

Sex Differences of Pulmonary Arterial Hypertension Patients With and Without Cardiopulmonary Comorbidities.

Canadian Cardiovascular Society/Canadian Heart Failure Society 2025 Guideline Update for Pharmacologic Management of Heart Failure With Nonreduced Ejection Fraction (LVEF > 40%)

Corrigendum to Canadian Cardiovascular Society/Canadian Heart Failure Society 2025 Guideline Update for Pharmacologic Management of Heart Failure With Nonreduced Ejection Fraction (LVEF > 40%). Volume 41, Issue 10, October 2025, Pages 1857-74

In search of the answers to the viability questions.

Risk Stratification in Cardiac Sarcoidosis&#xa0;With Cardiac Positron Emission Tomography: A Systematic Review and Meta-Analysis.

The HEARTRISK6 Scale: Predicting Short-Term Serious Outcomes in Emergency&#xa0;Department Acute Heart&#xa0;Failure Patients.

Characteristics, management, and outcomes in women and men with congestive heart failure in 40 countries at different economic levels: an analysis from the Global Congestive Heart Failure (G-CHF) registry

What's love got to do with it? Evaluating the Healing Hearts Together program on relationship, mental health, and cardiovascular outcomes

Multiparametric Cardiac Positron Emission Tomography for Cardiac Allograft Vasculopathy Surveillance After Heart Transplantation: MARINER Trial

COVID-19 Vaccine-Induced Inflammatory Heart Disease Prevalence Registry and Cohort Study (COVID-VIHPR)

Healing Hearts Together: Evaluating a couples-based intervention to improve health outcomes

Improving Care for Emergency Department and Pre-Hospital Patients with Acute and Life-Threatening Conditions

Altered Angiotensin II AT1 Receptor in Cardiac and Renal Disease: Translational Development of Novel F-18 Labeled Ligands for PET Imaging

Frequent collaborators

Nadia Giannetti

Douglas Lee

George Chandy

Sabina Keen

Amelia Yip

Harriette Van Spall

Abhinav Sharma

Jason Weatherald

Alexandra King

Doug Coyle

Salim Yusuf

Sharon Chih

Debra Eagles

Jason Weatherald

Steeve Provencher

Kwan-Leung Chan

Monica Taljaard

Eva Lonn

Heather Ross

Rob Beanlands

Lloyd Duchesne

Marino Labinaz

Martin Green

Renee Hessian

Anne Dipchand

Risk Stratification in Cardiac Sarcoidosis With Cardiac Positron Emission Tomography: A Systematic Review and Meta-Analysis.

The HEARTRISK6 Scale: Predicting Short-Term Serious Outcomes in Emergency Department Acute Heart Failure Patients.